Ildong Holdings Co., Ltd. (KRX:000230)
South Korea
· Delayed Price · Currency is KRW 6,910.00
-100.00 (-1.43%)
At close: Jun 26, 2025, 3:30 PM KST
Ildong Holdings Revenue
Ildong Holdings had revenue of 149.76B KRW in the quarter ending March 31, 2025, a decrease of -7.47%. This brings the company's revenue in the last twelve months to 645.47B, down -0.12% year-over-year. In the year 2024, Ildong Holdings had annual revenue of 657.57B with 2.99% growth.
Revenue (ttm)
645.47B
Revenue Growth
-0.12%
P/S Ratio
0.12
Revenue / Employee
8.96B
Employees
72
Market Cap
78.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 657.57B | 19.12B | 2.99% |
| Dec 31, 2023 | 638.45B | -37.09B | -5.49% |
| Dec 31, 2022 | 675.54B | 83.17B | 14.04% |
| Dec 31, 2021 | 592.37B | -4.09B | -0.69% |
| Dec 31, 2020 | 596.47B | 304.25B | 104.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |